Wall Street Experts
ver. ZuMIgo(08/25)
Adaptive Biotechnologies Corporation
Rachunek Zysków i Strat
Przychody TTM (mln): 177
EBIT TTM (mln): -184
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
| Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
38 |
56 |
85 |
98 |
154 |
185 |
170 |
179 |
| Przychód Δ r/r |
0.0% |
44.8% |
52.8% |
15.6% |
56.9% |
20.1% |
-8.1% |
5.1% |
| Marża brutto |
59.2% |
64.7% |
73.8% |
77.1% |
68.1% |
68.7% |
42.6% |
59.7% |
| EBIT (mln) |
-44 |
-50 |
-78 |
-153 |
-209 |
-200 |
-202 |
-163 |
| EBIT Δ r/r |
0.0% |
11.9% |
57.6% |
94.9% |
36.7% |
-4.2% |
0.7% |
-19.4% |
| EBIT (%) |
-115.7% |
-89.4% |
-92.1% |
-155.3% |
-135.4% |
-108.0% |
-118.4% |
-90.8% |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
4 |
14 |
12 |
| EBITDA (mln) |
-38 |
-44 |
-77 |
-151 |
-207 |
-194 |
-179 |
-129 |
| EBITDA(%) |
-96.2% |
-78.6% |
-90.2% |
-153.6% |
-134.3% |
-104.9% |
-105.3% |
-71.9% |
| Podatek (mln) |
-1 |
3 |
-10 |
-7 |
-2 |
-58 |
-0 |
0 |
| Zysk Netto (mln) |
-43 |
-46 |
-59 |
-140 |
-206 |
-142 |
-225 |
-159 |
| Zysk netto Δ r/r |
0.0% |
8.4% |
26.6% |
137.4% |
47.2% |
-30.7% |
58.1% |
-29.2% |
| Zysk netto (%) |
-111.4% |
-83.4% |
-69.1% |
-141.9% |
-133.2% |
-76.9% |
-132.3% |
-89.1% |
| EPS |
-0.41 |
-0.44 |
-0.85 |
-1.06 |
-1.46 |
-1.0 |
-1.56 |
-1.08 |
| EPS (rozwodnione) |
-0.41 |
-0.44 |
-0.85 |
-1.06 |
-1.46 |
-1.0 |
-1.56 |
-1.08 |
| Ilośc akcji (mln) |
105 |
105 |
69 |
131 |
140 |
143 |
144 |
147 |
| Ważona ilośc akcji (mln) |
105 |
105 |
69 |
131 |
140 |
143 |
144 |
147 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |